BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6896925)

  • 1. Müllerian-inhibiting substance: an update.
    Donahoe PK; Budzik GP; Trelstad R; Mudgett-Hunter M; Fuller A; Hutson JM; Ikawa H; Hayashi A; MacLaughlin D
    Recent Prog Horm Res; 1982; 38():279-330. PubMed ID: 6896925
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of monoclonal antibodies for affinity purification of bovine mullerian inhibiting substance activity.
    Shima H; Donahoe PK; Budzik GP; Kamagata S; Hudson P; Mudgett-Hunter M
    Hybridoma; 1984; 3(3):201-14. PubMed ID: 6548727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mullerian inhibiting substance inhibits colony growth of a human ovarian carcinoma cell line.
    Fuller AF; Guy S; Budzik GP; Donahoe PK
    J Clin Endocrinol Metab; 1982 May; 54(5):1051-5. PubMed ID: 6895900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioassay, purification, cloning, and expression of müllerian inhibiting substance.
    MacLaughlin DT; Epstein J; Donahoe PK
    Methods Enzymol; 1991; 198():358-69. PubMed ID: 1857229
    [No Abstract]   [Full Text] [Related]  

  • 5. Mullerian inhibiting substance: a fetal hormone with surgical implications.
    Hutson JM; Donahoe PK; Budzik GP
    Aust N Z J Surg; 1985 Dec; 55(6):599-605. PubMed ID: 2870703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antagonistic actions of testosterone and the anti-mullerian hormone on the mullerian duct of the chick embryo in culture in vitro].
    Weniger JP; Zeis A
    Arch Anat Microsc Morphol Exp; 1982; 71(2):99-106. PubMed ID: 6897160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insensitivity of the chick embryo müllerian duct to human recombinant müllerian-inhibiting substance.
    Weniger JP; Cate RL; Zeis A
    J Mol Endocrinol; 1992 Feb; 8(1):73-7. PubMed ID: 1543536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Müllerian inhibiting substance as a marker for ovarian sex-cord tumor.
    Gustafson ML; Lee MM; Scully RE; Moncure AC; Hirakawa T; Goodman A; Muntz HG; Donahoe PK; MacLaughlin DT; Fuller AF
    N Engl J Med; 1992 Feb; 326(7):466-71. PubMed ID: 1732773
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-müllerian hormone and lectins. New perspectives (author's transl)].
    Picard JY; Josso N
    Ann Endocrinol (Paris); 1980; 41(6):538-44. PubMed ID: 6894677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Müllerian inhibiting substance inhibition of a human endometrial carcinoma cell line xenografted in nude mice.
    Fuller AF; Budzik GP; Krane IM; Donahoe PK
    Gynecol Oncol; 1984 Jan; 17(1):124-32. PubMed ID: 6546372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic effects of müllerian inhibiting substance (MIS)?
    Janssens JP; Noto V; van Tendeloo G; Bonte J; de Loecker W
    Anticancer Res; 1988; 8(4):781-4. PubMed ID: 3178166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of anti-Müllerian hormone: another homology between Sertoli and granulosa cells.
    Vigier B; Picard JY; Tran D; Legeai L; Josso N
    Endocrinology; 1984 Apr; 114(4):1315-20. PubMed ID: 6546716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody to Mullerian inhibiting substance.
    Mudgett-Hunter M; Budzik GP; Sullivan M; Donahoe PK
    J Immunol; 1982 Mar; 128(3):1327-33. PubMed ID: 6895760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain.
    MacLaughlin DT; Hudson PL; Graciano AL; Kenneally MK; Ragin RC; Manganaro TF; Donahoe PK
    Endocrinology; 1992 Jul; 131(1):291-6. PubMed ID: 1612008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-müllerian hormone.
    Josso N
    Clin Endocrinol (Oxf); 1986 Sep; 25(3):331-45. PubMed ID: 3539417
    [No Abstract]   [Full Text] [Related]  

  • 16. [Precocious production of müllerian inhibitor by the fetal rabbit testis].
    Koike S; Jost A
    C R Seances Acad Sci III; 1982 Dec; 295(12):701-5. PubMed ID: 6820303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible purification of mullerian inhibiting substance and a model for its mechanism of action.
    Budzik GP; Donahoe PK; Hutson JM
    Prog Clin Biol Res; 1985; 171():207-23. PubMed ID: 2984697
    [No Abstract]   [Full Text] [Related]  

  • 18. Phosphorylation events during Müllerian duct regression.
    Hutson JM; Fallat ME; Kamagata S; Donahoe PK; Budzik GP
    Science; 1984 Feb; 223(4636):586-9. PubMed ID: 6607531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid enhancement of Mullerian duct regression.
    Ikawa H; Hutson JM; Budzik GP; MacLaughlin DT; Donahoe PK
    J Pediatr Surg; 1982 Oct; 17(5):453-8. PubMed ID: 6897422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Müllerian inhibiting substance: gene structure and mechanism of action of a fetal regressor.
    Donahoe PK; Cate RL; MacLaughlin DT; Epstein J; Fuller AF; Takahashi M; Coughlin JP; Ninfa EG; Taylor LA
    Recent Prog Horm Res; 1987; 43():431-67. PubMed ID: 3306839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.